Disease | pulmonary hypertension |
Phenotype | |heart disease |
Sentences | 69 |
PubMedID- 24039255 | Despite the importance of pulmonary veins in normal lung physiology and the pathobiology of pulmonary hypertension with left heart disease (ph-lhd), pulmonary veins remain largely understudied. |
PubMedID- 20595458 | Background: pulmonary artery occlusion pressure (paop) is used to differentiate patients with pulmonary hypertension (ph) associated with left-sided heart disease from other etiologies. |
PubMedID- 26502478 | The most common cause of ph, termed group 2 ph, is left-sided heart failure and is commonly known as pulmonary hypertension with left heart disease (ph-lhd). |
PubMedID- 23906950 | Group 2 comprises pulmonary hypertension owing to left heart disease; group 3, pulmonary hypertension owing to lung diseases and/or hypoxia; group 4, chronic thromboembolic pulmonary hypertension; and group 5, pulmonary hypertension of unknown cause. |
PubMedID- 23158820 | Conclusion: there was the expression of urotensin ii protein and mrna in the lung of pulmonary hypertension patients with congenital heart disease, and these expression may involve the formation of pulmonary hypertension of congenital heart disease. |
PubMedID- 24621657 | Background: pulmonary hypertension (ph) because of left-sided heart disease carries a poor prognosis. |
PubMedID- 20646485 | [inhaled iloprost during acute pulmonary vasodilator testing for preoperative assessment of surgical operability of congenital heart disease with severe pulmonary hypertension]. |
PubMedID- 23789186 | This article gives an overview of the importance and pathophysiology of pulmonary hypertension associated with left heart disease, and discusses the challenges associated with its diagnosis and treatment. |
PubMedID- 22884380 | pulmonary hypertension associated with left heart disease is the most common form of pulmonary hypertension encountered in clinical practice today. |
PubMedID- 25006452 | Repair of congenital heart disease with associated pulmonary hypertension in children: what are the minimal investigative procedures. |
PubMedID- 26291842 | Palliative senning in the treatment of congenital heart disease with severe pulmonary hypertension. |
PubMedID- 20136857 | Methods: eight congenital heart disease patients with pulmonary hypertension were studied and followed up during a 1-year period. |
PubMedID- 20592995 | Advanced valvular heart disease with secondary pulmonary hypertension due to impaired diastolic and/or systolic function of the left ventricle may support the occurrence of csa. |
PubMedID- 20144487 | Minimum-intensity projection of multidetector-row computed tomography for assessment of pulmonary hypertension in children with congenital heart disease. |
PubMedID- 22720870 | +: p < 0.05 in comparison to group 3, pulmonary hypertension owing to left heart disease (ph-lhd). |
PubMedID- 25011987 | Predictors of hospitalisations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: a systematic review. |
PubMedID- 24019248 | We report the clinical and histological findings and discuss about the impact of this unexpected and not-previously described associated lesion on the prognosis and on the therapeutic strategy in patients with pulmonary hypertension associated with congenital heart disease. |
PubMedID- 22360031 | Objectives: to evaluate the safety of valve replacement surgery in rheumatic heart disease patients with severe pulmonary hypertension (sph); defined as pulmonary artery systolic pressure (pasp > or = 60 mmhg) on patients operated for valve replacement at tabba heart institute, karachi. |
PubMedID- 24829371 | pulmonary hypertension in adults with congenital heart disease and eisenmenger syndrome: current advanced management strategies. |
Page: 1 2